Richmond Pharmacology is pleased to join Swiss Biotech Day 2026 in Basel, Switzerland, on 4-5 May 2026.

Recognised as one of Europe’s leading biotechnology events, Swiss Biotech Day brings together industry pioneers, investors, research institutions, and global life science innovators to explore new partnerships, cutting‑edge technologies, and the future of biotech‑driven healthcare.

Representing Richmond Pharmacology:

  • Dr Jörg Taubel, Chief Executive Officer
  • Stephen Wilkinson, Business Development Manager

Our Focus at the Conference

  • Emerging biotechnology platforms and novel therapeutic innovations
  • Early‑phase clinical development strategies
  • Regulatory, scientific, and partnering insights for global drug development
  • Collaboration opportunities across Europe’s expanding biotech landscape
  • Strengthening scientific, commercial, and translational partnerships

Connect With Us

If you are attending Swiss Biotech Day 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: Home - Swiss Biotech Day

Latest news

Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director

July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event